Wesley Jessen Wins PureVision Patent Suit; B&L Weighs Limited Options
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb is prohibited from selling its PureVision extended-wear contact lenses in the U.S. following a Washington, D.C. federal appeals court ruling Feb. 12
You may also be interested in...
Bausch & Lomb Predicts Strong Sales From PureVision Re-Launch In U.S.
Bausch & Lomb's planned U.S. re-launch of its PureVision silicone hydrogel contact lens in the second quarter could enable a repeat of the firm's 12% constant currency lens sales growth for 2004
Bausch & Lomb Predicts Strong Sales From PureVision Re-Launch In U.S.
Bausch & Lomb's planned U.S. re-launch of its PureVision silicone hydrogel contact lens in the second quarter could enable a repeat of the firm's 12% constant currency lens sales growth for 2004
Bausch & Lomb, Ciba Settlement Leaves No Outstanding Suits Between Firms
Bausch & Lomb will pay royalties on U.S. PureVision contact lens sales until 2014 under the terms of a silicone hydrogel technology cross-license with competitor Novartis/Ciba Vision